EIF4E and breast cancer: Ribavirin, one of antiviral drug, has been demonstrated to inhibit eIF4E by competing with the 7-methylguanosine mRNA cap, and has suppressed proliferation and the clonogenic potential of BC cells in vitro with the elevated levels of eIF4E [42,61,62].